| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |